Remove category spotlights
article thumbnail

Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options

IDStewardship

With more than 300 presentations available online, ID Podcasts excels at having a comprehensive database of content in multiple categories of infectious diseases. The ID Podcasts IOS app features ID news related content, and a comprehensive catalogue of ID presentations across more than 40 categories with extensive search features.

Hospitals 151
article thumbnail

Boehringer plans €25bn R&D spend, fuelled by Jardiance

pharmaphorum

On the digital health front, Boehringer also shone a spotlight on Click Therapeutics-partnered digital therapeutic CT-155 , a cognitive behavioural therapy app intended as an adjunct to drug treatment for patients with schizophrenia. The post Boehringer plans €25bn R&D spend, fuelled by Jardiance appeared first on.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Frontiers Health Steering Committee spotlight – Fredrik Debong

pharmaphorum

As we enter October and the Frontiers Health 2022 conference in Milan, we’re shining a spotlight on some of the Steering Committee members who have helped make the event what it is. When it comes to the horizontal plays, Debong sees two big categories. The other broad category is around data exchange.

article thumbnail

Andy Molnar named head of Digital Therapeutics Alliance

pharmaphorum

Molnar, who served as vice president of market access and government affairs at Cognoa, joins the four-year-old trade association at a time when the potential of using DTx to deliver remote healthcare has been thrust into the spotlight by the coronavirus pandemic. Andy Molnar.

97
article thumbnail

Silence Tx uses game to raise thalassaemia awareness

pharmaphorum

Our retro-inspired game in honor of #ITD2021 to shine a spotlight on #thalassemia and one of its most common symptoms #fatigue. Have you played #BloodRunBeta ? Play via the link and don’t forget to share your high score using #BloodRunBeta : [link]. — Silence Therapeutics (@SilenceTheraPlc) May 5, 2021.

94
article thumbnail

Straight after its first cancer bispecific OK, J&J highlights two more at ASCO

pharmaphorum

Also in the spotlight is teclistamab, which targets CD3 and BCMA, a myeloma target that already features in approved therapies, notably GlaxoSmithKline’s antibody-drug conjugate (ADC) Blenrep (belantamab mafodotin) and Bristol-Myers Squibb/bluebird bio’s Abecma CAR-T therapy (idecabtagene vicleucel).

FDA 87
article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

While the CRO category includes hundreds of small players, a handful of larger companies like, Parexel, PPD and others like Covance, ICON and Charles River Labs have grown into big multinational groups, often through serial acquisitions of their smaller counterparts.